NCT00215709View on ClinicalTrials.gov

Bi-Weekly Administration of Docetaxel for Older Men With Hormone Refractory Prostate Cancer

PHASE1CompletedINTERVENTIONAL

Enrollment

17

Participants

Timeline

Start Date

July 31, 2004

Study Completion Date

July 31, 2007

Conditions

Prostate Cancer

Interventions

DRUG

docetaxel

Trial Locations (1)

21211

Baltimore

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Sanofi

INDUSTRY

lead

Geriatric Oncology Consortium

OTHER